317
Views
44
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Economic Impact of Pulmonary Drugs on Direct Costs of Stable Chronic Obstructive Pulmonary Disease

, Ph.D. , M.D. & , Ph.D. , M.D.
Pages 215-223 | Published online: 18 Aug 2004

Figures & data

Table 1.  Average Registered Prices at the Time of the Study

Table 2.  Characteristics of 560 Patients by Stages of COPD Severity

Figure 1. A) Drug classes prescribed by general practicioners according to severity of the disease. B) Drug classes prescribed by pneumologists according to severity of the disease. C) Costs of each drug class according to severity of the disease. Mean drug costs in each group (Euros/patient/year).

Figure 1. A) Drug classes prescribed by general practicioners according to severity of the disease. B) Drug classes prescribed by pneumologists according to severity of the disease. C) Costs of each drug class according to severity of the disease. Mean drug costs in each group (Euros/patient/year).

Figure 2. Distribution of drug prescription based on severity by different consensus guidelines. (Full color version available online.)

Figure 2. Distribution of drug prescription based on severity by different consensus guidelines. (Full color version available online.)

Table 3.  Mean Number of Events and Mean Costs Per Year of Non‐Pharmaceutical On‐Pharmaceutical Direct Costs in Stable COPD According to Severity of Disease

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.